Literature DB >> 8672988

Lifetime alcohol consumption and breast cancer risk among postmenopausal women in Los Angeles.

M P Longnecker1, A Paganini-Hill, R K Ross.   

Abstract

Although most data support an overall relation of alcohol consumption with risk of breast cancer, the timing of alcohol consumption as it relates to risk of breast cancer is still debatable. The authors examined this issue in a case-control study conducted among non-Hispanic white and Hispanic women in Los Angeles. Cases aged 55-64 years at diagnosis in 1987-1989 were enrolled through the Cancer Surveillance Program of Los Angeles County (a Surveillance, Epidemiology, and End Results Program registry). Community controls were individually matched to cases by age (+/- 3 years), ethnicity, and neighborhood. In-person interviews were completed with 1510 matched pairs, of which 1431 met the inclusion criteria for the present analysis. In a multivariate conditional logistic regression model that simultaneously included terms for alcohol consumption at age 25 years, age 40 years, and in the recent past, clear differences among the age-specific associations were not observed, and the results suggested associations were not observed, and the results suggested that intake at each time independently contributed to risk. The odds ratios associated with estimated average lifetime intake were: for <6 g/day, 1.01; for 6-11 g/day, 1.21; for 12-18 g/day, 0.94; for 19-32 g/day, 1.63; for 33-45 g/day, 2.45 and for > or = 46 g/day, 0.94 compared with abstainers (P for trend = 0.01). Use of estrogen replacement therapy did not modify the risk associated with alcohol consumption, in contrast with the findings in two previous studies. This large study supports a relation between risk of breast cancer and alcohol consumption and suggests that lifetime intake may be the best indicator of alcohol-associated risk.

Entities:  

Mesh:

Year:  1995        PMID: 8672988

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  10 in total

1.  Lifetime Alcohol Intake, Binge Drinking Behaviors, and Breast Cancer Risk.

Authors:  Alexandra J White; Lisa A DeRoo; Clarice R Weinberg; Dale P Sandler
Journal:  Am J Epidemiol       Date:  2017-09-01       Impact factor: 4.897

Review 2.  Moderate alcohol consumption and breast cancer in women: from epidemiology to mechanisms and interventions.

Authors:  Philip J Brooks; Samir Zakhari
Journal:  Alcohol Clin Exp Res       Date:  2012-10-16       Impact factor: 3.455

3.  Alcohol intake over the life course and breast cancer survival in Western New York exposures and breast cancer (WEB) study: quantity and intensity of intake.

Authors:  Anne M Weaver; Susan E McCann; Jing Nie; Stephen B Edge; Thomas H Nochajski; Marcia Russell; Maurizio Trevisan; Jo L Freudenheim
Journal:  Breast Cancer Res Treat       Date:  2013-04-19       Impact factor: 4.872

4.  Proportion of invasive breast cancer attributable to risk factors modifiable after menopause.

Authors:  Brian L Sprague; Amy Trentham-Dietz; Kathleen M Egan; Linda Titus-Ernstoff; John M Hampton; Polly A Newcomb
Journal:  Am J Epidemiol       Date:  2008-06-13       Impact factor: 4.897

5.  Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease.

Authors:  N Hamajima; K Hirose; K Tajima; T Rohan; E E Calle; C W Heath; R J Coates; J M Liff; R Talamini; N Chantarakul; S Koetsawang; D Rachawat; A Morabia; L Schuman; W Stewart; M Szklo; C Bain; F Schofield; V Siskind; P Band; A J Coldman; R P Gallagher; T G Hislop; P Yang; L M Kolonel; A M Y Nomura; J Hu; K C Johnson; Y Mao; S De Sanjosé; N Lee; P Marchbanks; H W Ory; H B Peterson; H G Wilson; P A Wingo; K Ebeling; D Kunde; P Nishan; J L Hopper; G Colditz; V Gajalanski; N Martin; T Pardthaisong; S Silpisornkosol; C Theetranont; B Boosiri; S Chutivongse; P Jimakorn; P Virutamasen; C Wongsrichanalai; M Ewertz; H O Adami; L Bergkvist; C Magnusson; I Persson; J Chang-Claude; C Paul; D C G Skegg; G F S Spears; P Boyle; T Evstifeeva; J R Daling; W B Hutchinson; K Malone; E A Noonan; J L Stanford; D B Thomas; N S Weiss; E White; N Andrieu; A Brêmond; F Clavel; B Gairard; J Lansac; L Piana; R Renaud; A Izquierdo; P Viladiu; H R Cuevas; P Ontiveros; A Palet; S B Salazar; N Aristizabel; A Cuadros; L Tryggvadottir; H Tulinius; A Bachelot; M G Lê; J Peto; S Franceschi; F Lubin; B Modan; E Ron; Y Wax; G D Friedman; R A Hiatt; F Levi; T Bishop; K Kosmelj; M Primic-Zakelj; B Ravnihar; J Stare; W L Beeson; G Fraser; R D Bullbrook; J Cuzick; S W Duffy; I S Fentiman; J L Hayward; D Y Wang; A J McMichael; K McPherson; R L Hanson; M C Leske; M C Mahoney; P C Nasca; A O Varma; A L Weinstein; T R Moller; H Olsson; J Ranstam; R A Goldbohm; P A van den Brandt; R A Apelo; J Baens; J R de la Cruz; B Javier; L B Lacaya; C A Ngelangel; C La Vecchia; E Negri; E Marubini; M Ferraroni; M Gerber; S Richardson; C Segala; D Gatei; P Kenya; A Kungu; J G Mati; L A Brinton; R Hoover; C Schairer; R Spirtas; H P Lee; M A Rookus; F E van Leeuwen; J A Schoenberg; M McCredie; M D Gammon; E A Clarke; L Jones; A Neil; M Vessey; D Yeates; P Appleby; E Banks; V Beral; D Bull; B Crossley; A Goodill; J Green; C Hermon; T Key; N Langston; C Lewis; G Reeves; R Collins; R Doll; R Peto; K Mabuchi; D Preston; P Hannaford; C Kay; L Rosero-Bixby; Y T Gao; F Jin; J-M Yuan; H Y Wei; T Yun; C Zhiheng; G Berry; J Cooper Booth; T Jelihovsky; R MacLennan; R Shearman; Q-S Wang; C-J Baines; A B Miller; C Wall; E Lund; H Stalsberg; X O Shu; W Zheng; K Katsouyanni; A Trichopoulou; D Trichopoulos; A Dabancens; L Martinez; R Molina; O Salas; F E Alexander; K Anderson; A R Folsom; B S Hulka; L Bernstein; S Enger; R W Haile; A Paganini-Hill; M C Pike; R K Ross; G Ursin; M C Yu; M P Longnecker; P Newcomb; L Bergkvist; A Kalache; T M M Farley; S Holck; O Meirik
Journal:  Br J Cancer       Date:  2002-11-18       Impact factor: 7.640

6.  A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer.

Authors:  G Ursin; S London; F Z Stanczyk; E Gentzschein; A Paganini-Hill; R K Ross; M C Pike
Journal:  Environ Health Perspect       Date:  1997-04       Impact factor: 9.031

7.  Re: "A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer".

Authors:  H L Bradlow; G C Kabat
Journal:  Environ Health Perspect       Date:  1998-03       Impact factor: 9.031

8.  Alcohol consumption and breast cancer oestrogen and progesterone receptor status.

Authors:  S M Enger; R K Ross; A Paganini-Hill; M P Longnecker; L Bernstein
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

9.  Investigation of systemic folate status, impact of alcohol intake and levels of DNA damage in mononuclear cells of breast cancer patients.

Authors:  M M I Hussien; H McNulty; N Armstrong; P G Johnston; R A J Spence; Y Barnett
Journal:  Br J Cancer       Date:  2005-04-25       Impact factor: 7.640

10.  Alcohol and breast cancer risk: the alcoholism paradox.

Authors:  H Kuper; W Ye; E Weiderpass; A Ekbom; D Trichopoulos; O Nyrén; H O Adami
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.